+1
Resmed
For patients diagnosed with sleep apnea using Resmed-branded CPAP or bilevel devices for nightly therapy.
Known for
For patients diagnosed with sleep apnea using Resmed-branded CPAP or bilevel devices for nightly therapy.
Supporting patients with sleep apnea through digital companion tools designed to improve CPAP therapy adherence and monitoring.
Target audience
Portfolio
Free 4Last updated
myAir™ by Resmed
v4.7.0
3mo ago
Primary focus
Medical companion apps for sleep therapy
Scale
indie
Target audience
Patients diagnosed with sleep apnea using Resmed-branded CPAP or bilevel devices for nightly therapy.
Maintains a high update frequency for its flagship companion app, with 8 releases in the last 6 months to support hardware connectivity and user coaching.
4 apps analysed
Analysis in progress
Analysis in progress
Daily score tracking creates a sticky retention loop
Analysis in progress
Tightly focused on 5 markets (Australia, Brazil, Canada, Mexico, United States).
Based on 1 of 4 apps with localized market data — more coverage rolling in as scans complete · last scanned .
0
Positive apps
0
Neutral / mixed
1
Negative apps
25/100
Avg sentiment score
A dominant player in the remote medical monitoring space, setting the standard for patient-facing diagnostic hardware integration.
Strategic outlook coming soon.
What fed this analysis
Directly competes in the sleep monitoring niche by providing clinical-grade home sleep testing data.
High-velocity competitor in the patient adherence space, focusing on the broader medication management lifecycle.
Represents the gold standard for comprehensive patient-provider communication and health record access.
Emerging institutional app leveraging the MyChart ecosystem to provide localized, high-touch patient care.
Rapidly evolving communication platform with 11 releases in six months, signaling aggressive feature expansion.
